Product Overview: ATACAND PLUS AstraZeneca
Atacand Plus AstraZeneca is a pharmaceutical-grade combination compound comprising candesartan cilexetil and hydrochlorothiazide, enabling comprehensive cardiovascular research investigations. This dual-mechanism formulation allows researchers to study both angiotensin II receptor blockade and thiazide diuretic pathways within a single research protocol. The compound’s established pharmaceutical profile makes it valuable for comparative studies and mechanism validation research. Laboratory investigations can examine the synergistic effects of selective AT1 receptor antagonism combined with sodium-chloride cotransporter inhibition in various experimental models.
Cardiovascular Research Applications
Research teams investigating hypertension pathways frequently analyse this combination compound for its dual-target approach to blood pressure regulation mechanisms. Studies focus on the candesartan component’s selective angiotensin II type 1 receptor antagonism, which blocks vasoconstriction and aldosterone secretion pathways in experimental models. The hydrochlorothiazide component enables investigation of renal sodium handling and volume regulation through NCCT inhibition research. Comparative efficacy studies utilise this formulation alongside other cardiovascular research compounds available at Stroid UK Shop. Researchers examining combination therapy mechanisms often compare results with single-agent studies from our pharmaceutical research compounds category. Laboratory protocols investigating metabolic effects frequently incorporate findings from selective androgen receptor modulators to understand broader physiological interactions. Advanced research teams studying peptide-mediated cardiovascular effects reference comparative data from our research peptides collection for comprehensive mechanism analysis.
Technical Specifications
| Product Code | EU2161 |
|---|---|
| Manufacturer | AstraZeneca |
| Active Components | Candesartan Cilexetil + Hydrochlorothiazide |
| CAS Numbers | Verify with supplier documentation |
| Molecular Formula | Verify with supplier documentation |
| Storage Requirements | Room temperature, dry environment |
| Research Applications | Cardiovascular mechanism studies |
Research Compliance Statement
This Atacand Plus AstraZeneca compound is supplied exclusively for in-vitro laboratory research applications and scientific investigation purposes. The product is not intended for human consumption, therapeutic use, or any clinical application. All research must comply with institutional guidelines and applicable regulations governing pharmaceutical research compounds. Investigators should verify component specifications and implement appropriate safety protocols for laboratory handling and storage procedures.
